Mutual Advisors’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-9,370
Closed -$251K 1036
2023
Q3
$251K Buy
9,370
+462
+5% +$15.8K 0.01% 845
2023
Q2
$330K Sell
8,908
-930
-9% -$32.4K 0.01% 774
2023
Q1
$307K Buy
+9,838
New +$317K 0.01% 772
2022
Q4
Sell
-6,700
Closed -$255K 935
2022
Q3
$255K Hold
6,700
0.01% 762
2022
Q2
$365K Hold
6,700
0.02% 622
2022
Q1
$418K Sell
6,700
-1,826
-21% -$120K 0.02% 625
2021
Q4
$858K Buy
8,526
+726
+9% +$63.8K 0.05% 428
2021
Q3
$702K Buy
7,800
+460
+6% +$41.8K 0.04% 444
2021
Q2
$677K Sell
7,340
-300
-4% -$24K 0.04% 451
2021
Q1
$738K Sell
7,640
-1,960
-20% -$202K 0.05% 389
2020
Q4
$500K Sell
9,600
-400
-4% -$16.7K 0.04% 464
2020
Q3
$400K Sell
10,000
-10,000
-50% -$313K 0.03% 472
2020
Q2
$320K Sell
20,000
-15,000
-43% -$230K 0.03% 492
2020
Q1
$377K Sell
35,000
-21,600
-38% -$301K 0.05% 347
2019
Q4
$730K Sell
56,600
-48,480
-46% -$576K 0.08% 272
2019
Q3
$1.09M Sell
105,080
-69,797
-40% -$662K 0.14% 172
2019
Q2
$1.17M Sell
174,877
-5,000
-3% -$30.4K 0.15% 172
2019
Q1
$1.07M Sell
179,877
-14,805
-8% -$67.9K 0.16% 159
2018
Q4
$617K Sell
194,682
-44,700
-19% -$157K 0.12% 201
2018
Q3
$941K Sell
239,382
-50,618
-17% -$217K 0.14% 179
2018
Q2
$1.2M Sell
290,000
-77,861
-21% -$308K 0.27% 113
2018
Q1
$1.47M Sell
367,861
-11,550
-3% -$50.9K 0.37% 66
2017
Q4
$1.66M Buy
+379,411
New +$1.45M 0.63% 36

Other funds holding FLGT

Mutual Advisors's FLGT Position: Q4 2023 in Review

Mutual Advisors sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 9,370 shares — an estimated $251K sold.

Mutual Advisors first reported a position in FLGT in Q4 2017 and held it in 23 quarters. The position peaked at $1.66M in Q4 2017. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Mutual Advisors reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Mutual Advisors sold 9,370 Fulgent Genetics shares in Q4 2023, an estimated $251K.
  • Mutual Advisors first reported a position in Fulgent Genetics in Q4 2017 and held it in 23 quarters.
  • Mutual Advisors's Fulgent Genetics position peaked at $1.66M in Q4 2017.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Mutual Advisors's 13F filing for Q4 2023, filed 12 Jan 2024.